Amlodipine ameliorates myocardial hypertrophy by inhibiting EGFR phosphorylation
- 25 February 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 327 (4) , 1083-1087
- https://doi.org/10.1016/j.bbrc.2004.12.112
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Activation of Adenosine A 1 Receptor Attenuates Cardiac Hypertrophy and Prevents Heart Failure in Murine Left Ventricular Pressure-Overload ModelCirculation Research, 2003
- Characterization of Ca2+ channels involved in ET-1-induced transactivation of EGF receptorsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapyNature Medicine, 2002
- Calcium channel blockers in treatment of hypertensionProgress in Cardiovascular Diseases, 2001
- Suppression of EGF-induced cell proliferation by the blockade of Ca2+ mobilization and capacitative Ca2+ entry in mouse mammary epithelial cellsCell Biochemistry and Function, 2001
- Ectodomain Shedding of Epidermal Growth Factor Receptor Ligands Is Required for Keratinocyte Migration in Cutaneous Wound HealingThe Journal of cell biology, 2000
- CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivoJournal of Clinical Investigation, 2000
- Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated CardiomyopathyCell, 1999
- Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels.Proceedings of the National Academy of Sciences, 1996